Literature DB >> 217526

Genetic mechanisms in cancer predisposition: report of a cancer family.

L F Meisner, E Gilbert, H W Ris, G Haverty.   

Abstract

A family is described in which four children developed cancer affecting different organs:lymphoma, meningeal sarcoma, osteogenic sarcoma, and adenocarcinoma of the cecum. Since there was only one other case of cancer in previous generations of this family, an hypothesis is put forth to explain this unusual aggregation on the basis of recombination of common genes. It is postulated that each parent carried a different combination of genes which, though not associated with increased cancer predisposition in the combinations in which they were present in the parents, due to independent assortment resulted in a combination producing cancer susceptibility in half of the offspring. Such genetic loci could include factors similar to an oncogene which is normally held in control by genes at another locus; thus the dominant oncogene without the dominant controlling genes would make for cancer susceptibility, while the controlling genes without the oncogene would be associated with cancer resistance since two mutations would then be required for malignant development. To explain the occurrence of lymphoma in one of the children in this family, a third set of genes is included in this model--genes affecting immunocompetence, in which the normal allele is dominant. This three locus model has the advantage of being able to explain not only the occasional cancer family, but also the distribution of cancer susceptibility and resistance in the general population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217526     DOI: 10.1002/1097-0142(197902)43:2<679::aid-cncr2820430240>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Alpha-interferon and fragility at 16q22. A study on 15 selected controls and 146 selected patients.

Authors:  F Shabtai; J Orlyn; J Hart; S Bichacho; I Halbrecht
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

2.  Familial fragility on chromosome 16 (fra 16q22) enhanced by both interferon and Distamycin A.

Authors:  F Shabtai; D Klar; S Bichacho; J Hart; I Halbrecht
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes.

Authors:  Kevin B Jones; Joshua D Schiffman; Wendy Kohlmann; R Lor Randall; Stephen L Lessnick; Lisa A Cannon-Albright
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-17       Impact factor: 4.254

4.  Fragile sites and structural rearrangements in cancer.

Authors:  M De Braekeleer; B Smith; C C Lin
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice.

Authors:  Michael Rosemann; Iria Gonzalez-Vasconcellos; Tanja Domke; Virginija Kuosaite; Ralf Schneider; Markus Kremer; Jack Favor; Michaela Nathrath; Michael J Atkinson
Journal:  Mol Cancer       Date:  2014-08-04       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.